Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,912 | -1,423 | -5,108 | -3,428 | 476 |
| Depreciation Amortization | 15 | 8 | 45 | 39 | N/A |
| Accounts payable and accrued liabilities | -38 | -75 | 79 | 74 | N/A |
| Other Working Capital | -203 | -505 | 87 | -343 | 47 |
| Other Operating Activity | 321 | 243 | 368 | 386 | -5 |
| Operating Cash Flow | $-2,817 | $-1,752 | $-4,529 | $-3,272 | $518 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -6 | 66 | 70 | N/A |
| Other Investing Activity | 0 | 0 | 507 | 507 | 0 |
| Investing Cash Flow | $-6 | $-6 | $573 | $577 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 920 |
| Other Financing Activity | 0 | 0 | 522 | 522 | -90,750 |
| Financing Cash Flow | $N/A | $0 | $522 | $522 | $-89,830 |
| Exchange Rate Effect | -75 | -56 | -230 | -324 | N/A |
| Beginning Cash Position | 4,645 | 4,645 | 8,309 | 8,309 | 116,752 |
| End Cash Position | 1,747 | 2,831 | 4,645 | 5,812 | 27,439 |
| Net Cash Flow | $-2,898 | $-1,814 | $-3,664 | $-2,497 | $-89,312 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,817 | -1,752 | -4,529 | -3,272 | 518 |
| Capital Expenditure | -6 | -6 | -12 | -8 | N/A |
| Free Cash Flow | -2,823 | -1,758 | -4,541 | -3,280 | 518 |